Biosimilars for Retinal Diseases: An Update-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biosimilars for Retinal Diseases: An Update

Published:2021-04 Issue: Volume:224 Page:36-42
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Sharma Ashish^ORCID,Kumar Nilesh^ORCID,Parachuri Nikulaa,Bandello Francesco,Kuppermann Baruch D.,Loewenstein Anat

Publisher

Elsevier BV

Subject

Ophthalmology

Reference25 articles.

1. Book review: Anti-VEGF use in ophthalmology;Vora;Int J Retin Vitr,2017

2. Medicare spending on anti-vascular endothelial growth factor medications;Patel;Ophthalmol Retina,2018

3. Factors affecting compliance to intravitreal anti-vascular endothelial growth factor therapy in Indian patients with retinal vein occlusion, age-related macular degeneration, and diabetic macular edema;Kelkar;Indian J Ophthalmol,2020

4. Biosimilars in ophthalmology: Is there a big change on the horizon?;Sharma;Clin Ophthalmol,2018

5. Understanding biosimilars and its regulatory aspects across the globe: an ophthalmology perspective;Sharma;Br J Ophthalmol,2020

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI);Eye;2024-08-26

2. Biosimilars of anti-vascular endothelial growth factor for ophthalmic diseases: A review;Survey of Ophthalmology;2024-07

3. Visual Outcome and Fluid Changes Between Eyes With Polypoidal Choroidal Vasculopathy Receiving Biosimilar CKD-701 or Reference Ranibizumab Therapy: A Post Hoc Analysis of a Phase 3 Randomized Clinical Trial;Current Eye Research;2024-03-07

4. Injection Frequency and Differences in Visual Outcomes based on Diagnosis Year in Neovascular Age-related Macular Degeneration;Journal of the Korean Ophthalmological Society;2024-02-15

5. Treatment of diabetic macular edema: Bibliometric analysis;2024-01-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3